Cellmetrix, Inc. - CLMI- Profile

Cellmetrix, Inc.. The Company develops and markets clinical testing applications and automated laboratory systems for detection, diagnosis and treatment of human diseases. In September 1999, the company acquired LungCheck Inc, which owns the LungCheck(R) technology. This technology is used for detecting Lung diseases such as cancer and provide a specialised sputum cytology laboratory service which includes assessment of pulmonary health of lung cells. Prior to the acquisition of LungCheck, the Company was software and technology consultancy firm specializing in providing ergonomic solutions to individuals, corporate bodies and government entities. Develops and markets clinical testing applications for early detection and treatment of human diseases